» Articles » PMID: 32406380

EBreCaP: Extreme Learning-based Model for Breast Cancer Survival Prediction

Overview
Journal IET Syst Biol
Publisher Wiley
Specialty Biology
Date 2020 May 15
PMID 32406380
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is the second leading cause of death in the world. Breast cancer research is focused towards its early prediction, diagnosis, and prognosis. Breast cancer can be predicted on omics profiles, clinical tests, and pathological images. The omics profiles comprise of genomic, proteomic, and transcriptomic profiles that are available as high-dimensional datasets. Survival prediction is carried out on omics data to predict early the onset of disease, relapse, reoccurrence of diseases, and biomarker identification. The early prediction of breast cancer is desired for the effective treatment of patients as delay can aggravate the staging of cancer. In this study, extreme learning machine (ELM) based model for breast cancer survival prediction named eBreCaP is proposed. It integrates the genomic (gene expression, copy number alteration, DNA methylation, protein expression) and pathological image datasets; and trains them using an ensemble of ELM with the six best-chosen models suitable to be applied on integrated data. eBreCaP has been evaluated on nine performance parameters, namely sensitivity, specificity, precision, accuracy, Matthews correlation coefficient, area under curve, area under precision-recall, hazard ratio, and concordance Index. eBreCaP has achieved an accuracy of 85% for early breast cancer survival prediction using the ensemble of ELM with gradient boosting.

Citing Articles

Comparative analysis of features and classification techniques in breast cancer detection for Biglycan biomarker images.

Matouq J, Alnuman N Cancer Biomark. 2024; 40(3-4):263-273.

PMID: 39177590 PMC: 11380270. DOI: 10.3233/CBM-230544.


Publicly available datasets of breast histopathology H&E whole-slide images: A scoping review.

Tafavvoghi M, Bongo L, Shvetsov N, Rasmussen Busund L, Mollersen K J Pathol Inform. 2024; 15:100363.

PMID: 38405160 PMC: 10884505. DOI: 10.1016/j.jpi.2024.100363.


FGCNSurv: dually fused graph convolutional network for multi-omics survival prediction.

Wen G, Li L Bioinformatics. 2023; 39(8).

PMID: 37522887 PMC: 10412406. DOI: 10.1093/bioinformatics/btad472.


The research on TBATS and ELM models for prediction of human brucellosis cases in mainland China: a time series study.

Zhao D, Zhang H BMC Infect Dis. 2022; 22(1):934.

PMID: 36510150 PMC: 9746081. DOI: 10.1186/s12879-022-07919-w.


Software system to predict the infection in COVID-19 patients using deep learning and web of things.

Singh A, Kaur A, Dhillon A, Ahuja S, Vohra H Softw Pract Exp. 2021; 52(4):868-886.

PMID: 34538962 PMC: 8441673. DOI: 10.1002/spe.3011.


References
1.
Tabl A, Alkhateeb A, ElMaraghy W, Rueda L, Ngom A . A Machine Learning Approach for Identifying Gene Biomarkers Guiding the Treatment of Breast Cancer. Front Genet. 2019; 10:256. PMC: 6446069. DOI: 10.3389/fgene.2019.00256. View

2.
Wang Z, Wang C . Buckley-James boosting for survival analysis with high-dimensional biomarker data. Stat Appl Genet Mol Biol. 2010; 9:Article24. PMC: 2904263. DOI: 10.2202/1544-6115.1550. View

3.
J van t Veer L, Dai H, van de Vijver M, He Y, Hart A, Mao M . Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415(6871):530-6. DOI: 10.1038/415530a. View

4.
Ching T, Himmelstein D, Beaulieu-Jones B, Kalinin A, Do B, Way G . Opportunities and obstacles for deep learning in biology and medicine. J R Soc Interface. 2018; 15(141). PMC: 5938574. DOI: 10.1098/rsif.2017.0387. View

5.
Hung F, Chiu H . Cancer subtype prediction from a pathway-level perspective by using a support vector machine based on integrated gene expression and protein network. Comput Methods Programs Biomed. 2017; 141:27-34. DOI: 10.1016/j.cmpb.2017.01.006. View